IMGN151: Clinical Trials

1 trial of IMGN151, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1

Follow IMGN151: new trials by email Literature Review of IMGN151 trials Research Report on IMGN151

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
IMGN151 - Endometrial Cancer, High Grade Serous Adenocarcinoma of Ovary
Phase 1Active not recruitingAbbVie2562023-01-112026-02-20

Conditions studied

Endometrial Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Recurrence (1)  ·  Uterine Cervical Neoplasms (1)

Sponsors

AbbVie (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United States (1)

NIH funding

2023 (1)